Dr. David Samadi:Mitt Romney’s Prognosis Good after Prostate Surgery

According to urology expert Dr. David Samadi, the prognosis for the recovery from prostate cancer for Mitt Romney, the former Republican presidential candidate, is good. Dr. Samadi, chief of Robotic Surgery and chairman of Urology at Lenox Hill Hospital, said Romney’s cancer has been successfully treated through surgery. Romney had been diagnosed with a slow-growing cancerous tumor and underwent prostate surgery a few months ago. Some say his cancer disclosure and announcement of his clean bill of health is a sign he plans to run for Orin Hatch’s Utah seat in the U.S. Senate.

Dr. Thomas Ahlering successfully performed the surgery at California’s UC Irvine Hospital and Romney’s prognosis is said to be good. In 2017, over 161,360 men were diagnosed with prostate cancer and the American Cancer Society estimates in 2018 there will be 164,690 new prostate cancer cases confirmed. About 60% of men diagnosed with prostate cancer are over age 65. The 70 year old Romney joins politicians Colin Powell, former Secretary of State, and former Democratic presidential candidate John Kerry as well-known men that had successful surgical treatment for prostate cancer.

Dr. Samadi, a Hofstra School of Medicine urology professor, says men diagnosed with prostate cancer must look at the pros and cons and before deciding between surgery and radiation treatment. Dr. Samadi recommends surgery if the cancer is confined to the prostate gland. Studies show in those cases men had better outcomes with surgery than radiation treatment. Dr. Samadi pointed out that men who opt for radiation treatment die sooner and twice as often as those choosing surgery. Radiation treatment patients also often develop rectal, bladder and other secondary cancers.

A board-certified urologist, Dr. David Samadi specializes in prostate cancer diagnosis and treatment. He has a degree in biochemistry from Stony Brook University and graduated from Stoney Brook School of Medicine with his M.D. He attended Montefiore Medical Center to do postgraduate training in urology. He went to Albert Einstein College of Medicine for advanced training in proctology. In 2001, Dr. Samadi was at Memorial Sloan Kettering Cancer Center completing an oncology fellowship focused on proctology. He also studied in France under Professor Claude Abbou at Henri Mondor Hospital Cretail for a fellowship in robotic radical prostatectomy.

Dr. David Samadi said men diagnosed prostate cancer should select an experienced, qualified urologist/oncologist to provide the guidance they need to make informed decisions about overcoming the disease.